Baxter International lung therapy devices recall classified most serious by USFDA
The FDA said the adaptor may prevent patients from getting enough oxygen from their ventilators, and possibly lead to death if caregivers are not trained properly.
New Delhi: The U.S. Food and Drug Administration (USFDA) on Thursday classified the recall of some Baxter International Inc's lung therapy devices as the most serious type after reports of two deaths.
Medical device maker Baxter in late April recalled about 268 devices distributed between May 28, 2020 and April 19, 2022.
Read also: Pfizer sued for patent infringement over COVID-19 drug Paxlovid
The device, Volara, is used to deliver therapies for several conditions such as for lung complications. Its ventilator adaptor component allows the device to be used with ventilators in home-care settings.
The FDA said the adaptor may prevent patients from getting enough oxygen from their ventilators, and possibly lead to death if caregivers are not trained properly.
Read also: USFDA investigates death of another infant given Abbott formula: Bloomberg
